← BRISTOL MYERS SQUIBB CO

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Total Revenue $19.4b
$20.8b +6.94%
$22.6b +8.59%
$26.1b +15.89%
$42.5b +62.62%
$46.4b +9.09%
$46.2b -0.49%
$45.0b -2.50%
$48.3b +7.32%
$48.2b -0.22%
$49.2b +2.06%
Cost of Revenue $4.9b
$6.1b +22.64%
$6.5b +7.93%
$8.1b +23.38%
$11.8b +45.74%
$9.9b -15.57%
$10.1b +1.98%
$10.7b +5.48%
$14.0b +30.63%
$13.9b -0.23%
$14.7b +5.32%
Gross Profit $14.5b
$14.7b +1.58%
$16.0b +8.86%
$18.1b +12.82%
$30.7b +70.17%
$36.4b +18.54%
$36.0b -1.16%
$34.3b -4.74%
$34.3b +0.06%
$34.3b -0.22%
$34.5b +0.73%
Research and Development Expense $4.9b $6.4b $6.3b $6.1b $11.1b $11.4b $9.5b $9.3b $11.2b $10.0b $10.7b
Marketing and Advertising Expense $789.0m $740.0m $672.0m $633.0m $990.0m $1.3b $1.3b $1.4b $1.5b $1.3b —
Selling, General and Administrative Expense $4.9b $4.7b $4.6b $4.9b $7.7b $7.7b $7.8b $7.8b $8.4b $7.3b $7.4b
Amortization of Intangible Assets $178.0m $190.0m $198.0m $1.3b $9.9b $10.2b $9.7b $9.2b $9.0b $3.5b —
Operating expenses:
Interest Expense $167.0m $196.0m $183.0m $656.0m $1.4b $1.3b $1.2b $1.2b — — $1.7b
Equity Securities, FV-NI, Realized Gain (Loss) — — $7.0m $14.0m ($12.0m) $357.0m $17.0m $3.0m ($32.0m) $4.0m —
Foreign Currency Transaction Gain (Loss), Realized $52.0m — — — — — — — — — —
Gain (Loss) Related to Litigation Settlement ($47.0m) $487.0m ($76.0m) ($77.0m) $194.0m ($82.0m) ($178.0m) $390.0m ($84.0m) ($434.0m) —
Gain (Loss) on Investments — — — — — — ($801.0m) ($160.0m) $16.0m $280.0m —
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement — — — — — — — — ($119.0m) — —
Income (Loss) from Equity Method Investments $77.0m $75.0m $93.0m ($4.0m) — $231.0m ($108.0m) ($38.0m) $44.0m $47.0m —
Interest Expense (non-operating) — — — — — — — — $1.9b $1.9b $1.7b
Other Nonoperating Income (Expense) $1.3b $1.5b $850.0m ($938.0m) $2.3b $720.0m ($576.0m) $1.2b ($893.0m) ($674.0m) —
Income (Loss) from Continuing Operations before Income Taxes, Domestic $3.1b $2.3b $2.3b $542.0m ($10.1b) $1.6b ($140.0m) $2.6b ($14.9b) ($19.0m) $11.9b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest — — — — — $8.1b $7.7b $8.4b ($8.4b) $9.3b $11.9b
Current Income Tax Expense (Benefit) $1.6b $3.1b $935.0m $2.4b $1.1b $2.5b $4.1b $3.7b $2.6b $3.2b $2.6b
Income Tax Expense (Benefit) $1.4b $4.2b $1.0b $1.5b $2.1b $1.1b $1.4b $400.0m $554.0m $2.3b $2.6b
Net Income (Loss) Attributable to Parent $4.5b
$1.0b -77.41%
$4.9b +388.58%
$3.4b -30.10%
($9.0b) -362.14%
$7.0b +177.58%
$6.3b -9.54%
$8.0b +26.84%
($8.9b) -211.50%
$7.1b +178.83%
$9.3b +31.58%
Net Income (Loss) Attributable to Noncontrolling Interest $50.0m ($32.0m) $27.0m $21.0m $20.0m $20.0m $18.0m — — — $9.3b
Earnings Per Share, Basic $2.67 $0.61 $3.01 $2.02 ($3.99) $3.15 $2.97 $3.88 ($4.41) $3.47 $4.56
Earnings Per Share, Diluted $2.65 $0.61 $3.01 $2.01 ($3.99) $3.12 $2.95 $3.86 ($4.41) $3.46 $4.54
Common Stock, Dividends, Per Share, Declared $1.53 $1.57 $1.61 $1.68 $1.84 $2.01 $2.19 $2.31 $2.42 $2.49 —
Weighted Average Number of Shares Outstanding, Basic 1.7b 1.6b 1.6b 1.7b 2.3b 2.2b 2.1b 2.1b 2.0b 2.0b 2.0b
Weighted Average Number of Shares Outstanding, Diluted 1.7b 1.7b 1.6b 1.7b 2.3b 2.2b 2.1b 2.1b 2.0b 2.0b 2.0b
Additional Financial Items
Business Combination, Acquisition Related Costs — — — $657.0m $0 $0 — — — — —
Costs and Expenses $13.5b $15.6b $16.6b $21.2b $49.4b $38.3b $38.4b $36.6b $56.7b $38.9b —
Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount — — — — ($204.0m) — — — — — —

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.